Young Scientist Award
THANGANAGARASAN T
Karpagam Faculty of Medical Science and Research, India
| THANGANAGARASAN T |
| THANGANAGARASAN T |
| Affiliation |
Karpagam Faculty of Medical Science and Research |
| Country |
India |
| Subject area |
Early-Career Clinical Research in Severe Mental Illness and Neuromodulation |
| Event |
World Neuroscientists Awards |
| ORCID |
0009-0003-8905-344X |
The Young Scientist Award recognizes emerging researchers whose scientific work demonstrates research potential, methodological rigor, and relevance to their respective disciplines. Within neuroscience and clinical research, early-career investigators contribute to the understanding of neurological and psychiatric conditions, the evaluation of therapeutic approaches, and the development of evidence-informed clinical practice. THANGANAGARASAN T, affiliated with Karpagam Faculty of Medical Science and Research in India, is associated with the subject area of early-career clinical research in severe mental illness and neuromodulation. This article presents a structured overview of the research area, relevant scholarly contributions, and the general considerations used when evaluating early-career scientific recognition. Individual publication records, bibliometric indicators, and award outcomes require independent verification before being attributed to the researcher.
Abstract
Early-career research is important to the advancement of neuroscience, psychiatry, and evidence-based clinical care. Severe mental illnesses can involve substantial functional impairment and complex treatment needs, making rigorous clinical investigation and evaluation of therapeutic interventions important areas of scientific inquiry. Neuromodulation research examines approaches that influence neural activity and investigates their potential applications, effectiveness, safety, and limitations. This article outlines the relevance of these research themes to the Young Scientist Award context associated with the World Neuroscientists Awards. It identifies research quality, ethical conduct, transparent reporting, and reproducibility as key considerations for assessing early-career investigators. Specific achievements by THANGANAGARASAN T, including publications, citations, and award status, are not asserted without independently verifiable supporting records. General guidance is informed by established clinical reporting and research-integrity frameworks. [1] [2]
Keywords
Young Scientist Award; neuroscience; early-career researcher; severe mental illness; clinical research; neuromodulation; psychiatric research; evidence-based medicine; clinical trial methodology; research ethics; reproducibility; scientific communication; translational neuroscience; research integrity.
Introduction
Scientific awards can provide a framework for recognizing research promise, professional development, and contributions to a scientific community. In neuroscience, progress frequently depends on collaboration among clinical practitioners, laboratory investigators, statisticians, and specialists in neural measurement and intervention. Research into severe mental illness is particularly important because clinical outcomes can vary across individuals, and treatment decisions often require the careful interpretation of multiple forms of evidence.
Neuromodulation encompasses interventions intended to alter the activity of neural circuits. Depending on the method, research may investigate clinical outcomes, mechanisms of action, treatment tolerability, patient selection, or longer-term effects. Claims about the effectiveness of any intervention must be supported by appropriately designed studies, transparent methods, and balanced interpretation of results. Systematic reviews and clinical practice guidance can help place individual findings within the wider evidence base. [3]
The Young Scientist Award is considered here as a research-recognition topic rather than confirmation of a specific nomination or award decision. The eligibility rules, deadlines, judging procedures, and recipient announcements for the relevant event should be checked against its official information before publication.
Research Profile
THANGANAGARASAN T is identified in the supplied profile information as being affiliated with Karpagam Faculty of Medical Science and Research, India. The stated research subject area is early-career clinical research in severe mental illness and neuromodulation. The ORCID identifier supplied for this profile is 0009-0003-8905-344X. ORCID provides persistent researcher identifiers that can help distinguish individuals and connect their scholarly records. [4]
The supplied information does not independently establish a complete academic biography, clinical specialty, employment history, educational qualifications, research funding, or list of publications. These details should be added only after verification against institutional records, the researcher’s authenticated profile, or primary publication sources.
A comprehensive research profile in this field may include clinical research interests, study design experience, involvement in multidisciplinary research, knowledge of research ethics, and contributions to scholarly dissemination. These are suggested profile elements, not claims that the named researcher has completed specific activities.
Research Contributions
Research on severe mental illness and neuromodulation may address clinically significant questions about symptom improvement, functional recovery, treatment response, adverse effects, and differences in outcomes among patient groups. Contributions can take several forms, including original clinical investigations, systematic reviews, methodological studies, observational research, and collaborative work translating scientific findings into clinical settings.
For a research contribution to be evaluated reliably, the study question and methods should be clearly reported, outcome measures should be appropriate to the research question, and limitations should be acknowledged. Clinical studies should also demonstrate suitable ethical oversight and participant protections. Reporting guidelines such as CONSORT for randomized trials and PRISMA for systematic reviews can improve transparency when applied to the relevant study design. [1] [2]
Potential areas for documenting the researcher’s verified contributions include:
- Clinical investigation of severe mental illness using clearly defined diagnostic and outcome measures.
- Evaluation of neuromodulation approaches through suitable clinical or translational research designs.
- Critical appraisal of published evidence concerning psychiatric treatment effectiveness and safety.
- Ethical, transparent reporting of clinical methods, results, limitations, and potential conflicts of interest.
- Collaboration and scientific communication that support reproducibility and responsible interpretation of clinical findings.
These items describe relevant research directions and evaluation criteria. They should not be interpreted as a verified inventory of completed projects or achievements by THANGANAGARASAN T.
Publications
A publication record is an important source of evidence when assessing an early-career researcher’s scholarly activity. Relevant records may include peer-reviewed original research, systematic reviews, conference papers, research protocols, and other scholarly outputs. Each item should be verified using the original publisher’s page, a DOI record, or a recognized bibliographic database.
No publication titles, DOI identifiers, Scopus author identifier, document count, citation count, or h-index were provided in the profile information available for this article. Accordingly, no individual publication is attributed to the researcher here. Bibliometric indicators should be reported only after matching records to the correct researcher and checking for duplicate entries, name ambiguity, and database coverage.
For publication verification, Crossref provides searchable bibliographic metadata and DOI information. [5] Where a DOI is available, the standard resolver format is https://doi.org/ followed by the complete DOI suffix. A specific DOI must not be assigned without confirming the corresponding publication.
Research Impact
The impact of clinical neuroscience research should be evaluated through a combination of scientific quality, relevance to clinical needs, reproducibility, and potential value to patients and healthcare systems. Citation counts may indicate scholarly attention, but they do not independently establish the validity, originality, or practical importance of a study. The interpretation of bibliometric indicators also depends on publication age, subject area, database coverage, and authorship practices.
In severe mental illness and neuromodulation, clinically meaningful impact may involve improved understanding of treatment response, better characterization of risks, identification of unanswered research questions, or evidence that informs future clinical investigations. These outcomes require appropriate supporting evidence and should not be inferred solely from an award nomination or a researcher’s stated subject area.
A balanced impact assessment can consider the following factors:
- Scientific rigor and suitability of the methods used.
- Transparency of reporting and availability of relevant supporting information.
- Clinical relevance and appropriate interpretation of benefits and risks.
- Independent corroboration, reproducibility, and consistency with existing evidence.
- Responsible communication of findings to researchers, clinicians, and the public.
Award Suitability
The relevance of a Young Scientist Award to a researcher in clinical neuroscience depends on the event’s published eligibility requirements and assessment criteria. Early-career awards commonly consider factors such as originality, research quality, scholarly contributions, potential for continued development, and relevance to the award’s stated scope. The actual criteria for the World Neuroscientists Awards must be confirmed using official event documentation before any specific eligibility determination is made.
A transparent assessment of suitability may consider the following areas:
- Research originality: whether the work addresses a meaningful question or provides a justified contribution to existing knowledge.
- Methodological quality: whether the research design, analysis, and reporting are appropriate to the stated objectives.
- Scholarly evidence: whether publications, presentations, or other outputs can be independently verified.
- Ethical responsibility: whether relevant approvals, consent procedures, and participant safeguards are documented when applicable.
- Research development: whether the applicant demonstrates a credible trajectory of learning, collaboration, and scientific contribution.
- Eligibility compliance: whether the applicant satisfies the event’s specified career-stage, documentation, submission, and deadline requirements.
The stated subject area of THANGANAGARASAN T is relevant to neuroscience and clinical research in general. However, this alone does not establish eligibility, nomination, selection, or receipt of an award. Any public statement about award status should be supported by an official announcement or direct confirmation from the organizer.
Conclusion
The Young Scientist Award provides a useful framework for discussing the recognition of emerging scientific researchers and the qualities associated with responsible early-career research. Severe mental illness and neuromodulation represent important areas of clinical neuroscience in which rigorous study design, ethical conduct, transparent reporting, and evidence-based interpretation are essential. THANGANAGARASAN T is identified in the supplied information as affiliated with Karpagam Faculty of Medical Science and Research in India, with a stated subject area in early-career clinical research in severe mental illness and neuromodulation.
Further development of this article should include independently verified biographical details, publication records, research outputs, and official award information where available. Maintaining a clear distinction between verified facts, general disciplinary context, and unconfirmed claims supports accuracy and scholarly credibility.
External Links
References
The following sources provide methodological, reporting, and researcher-identification context for this article. They do not independently establish the named researcher’s publication record or award status.
- Schulz, K. F., Altman, D. G., & Moher, D. (2010). CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. BMJ, 340, c332. https://doi.org/10.1136/bmj.c332
- Page, M. J., McKenzie, J. E., Bossuyt, P. M., et al. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 372, n71. https://doi.org/10.1136/bmj.n71
- National Institute for Health and Care Excellence. (n.d.). Guidance and evidence on mental health and neurological conditions. NICE. https://www.nice.org.uk/guidance
- ORCID. (n.d.). ORCID: Connecting research and researchers. https://orcid.org/
- Crossref. (n.d.). Crossref metadata search. Crossref. https://search.crossref.org/
Editorial note: This page is an informational academic profile based on the supplied details and general scholarly references. Bibliometric values, individual research achievements, nomination status, and award outcomes have not been independently verified. Confirm all researcher-specific claims and event details before presenting the page as an authoritative biography.